Senseonics, in partnership with global commercial partner Ascensia Diabetes Care and St. Louis-based Mercy, a health care system and accountable care organization, announced a first-of-its-kind relationship in a diabetes population management program. The collaboration marks the first time Senseonics’ Eversense CGM technology will be used across a health system and the first implementation of Senseonics’ new Eversense Remote Patient Monitoring solution to drive significant advancement in diabetes management for patients.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SENS:
- Options Volatility and Implied Earnings Moves Today, May 13, 2024
- Options Volatility and Implied Earnings Moves This Week, May 13 – May 16, 2024
- Senseonics Holdings Inc. (SENS) Q1 Earnings Cheat Sheet
- Senseonics Eversense granted integrated CGM designation by FDA
- Senseonics Board Shift: Schumm Out, Hansen In Until 2025